LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-10-06
Case ID: NM_000314.8_c.722_723dup_20261006_141310
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.722_723dup

PTEN  · NP_000305.3:p.(Glu242LeufsTer15)  · NM_000314.8
GRCh37: chr10:89717695 C>CTT  ·  GRCh38: chr10:87957938 C>CTT
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Glu242LeufsTer15)
gnomAD AF
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 very strong: the p.E242Lfs*15 frameshift is 5' of the PTEN VCEP p.D375 NMD threshold and is predicted to undergo nonsense-mediated decay.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1, satisfying the PTEN VCEP population-frequency rule.
Final determination: PTEN Expert Panel Rule20 assigns Likely Pathogenic when one very strong pathogenic criterion and one supporting pathogenic criterion are present; here these are PVS1 very strong and PM2 supporting.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met: the p.E242Lfs*15 frameshift is 5' of the PTEN VCEP p.D375 NMD threshold, so the decision tree assigns full-strength PVS1.
cspec vcep_pvs1_decisiontree_pten
PS1 N/A Not applicable: c.722_723dup is a frameshift, whereas PTEN PS1 requires a pathogenic same-amino-acid or qualifying splice-site comparison.
cspec
PS2 Not assessed Not assessed: no documented proband-level parental testing, confirmed maternity and paternity, or absence of family history for c.722_723dup.
cspec
PS3 Not assessed Not assessed: the governing PTEN assay table covers missense variants and contains no entry for this frameshift, c.722_723dup / p.E242Lfs*15.
cspec vcep_mmc2
PS4 Not assessed Not assessed: no variant-specific specificity score or qualifying case-control odds ratio, p value, and confidence interval are available for c.722_723dup.
cspec PMID:21194675 PMID:9467011
PM1 Not met Not met: residue 242 is outside PTEN VCEP critical motifs 90-94, 123-130, and 166-168, and no E242 hotspot was identified.
cspec
PM2 Met Met at supporting: the variant is absent from gnomAD v2.1 and v4.1, satisfying the PTEN PM2 absence criterion below 0.00001 allele frequency.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP explicitly designates PM3 as not applicable for this autosomal-dominant disorder.
cspec
PM4 Not met Not met: p.E242Lfs*15 is a frameshift with premature termination, whereas the PTEN PM4 rule requires an in-frame length change or stop-loss extension.
cspec
PM5 N/A Not applicable: c.722_723dup is a frameshift, while PTEN PM5 requires a different pathogenic missense change at the same residue.
cspec
PM6 Not assessed Not assessed: no documented presumed de novo proband observation, parental testing status, or family-history assessment for c.722_723dup.
cspec
PP1 Not assessed Not assessed: zero informative meioses or exact-variant affected-relative segregation data are documented, below the PTEN VCEP minimum of 3 meioses.
cspec
PP2 N/A Not applicable: PP2 is missense-specific, but c.722_723dup produces the frameshift p.(Glu242LeufsTer15).
cspec
PP3 N/A Not applicable: c.722_723dup is a frameshift variant, outside PP3's calibrated missense or intronic/splice-region computational scope.
PP4 N/A Not applicable: the PTEN Expert Panel framework incorporates phenotype specificity into PS4 and explicitly excludes independent PP4 use.
cspec
PP5 N/A Not applicable: PP5 is excluded by the PTEN framework, and ClinVar has no exact-variant expert-panel Pathogenic assertion.
cspec clinvar
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the PTEN BA1 threshold of 0.00056 allele frequency.
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, below both PTEN BS1 intervals beginning at 0.0000043 allele frequency.
cspec gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: no homozygous observation in a healthy or PHTS-unaffected individual is available to satisfy the PTEN BS2 rule.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no variant-specific benign functional result was found for the frameshift c.722_723dup / p.E242Lfs*15 in the governing PTEN assay material.
cspec vcep_mmc2
BS4 Not assessed Not assessed: no tested affected relatives or family-level non-segregation observations are documented for c.722_723dup.
cspec
BP1 N/A Not applicable: the PTEN VCEP excludes BP1, and this variant is a frameshift rather than a missense change.
cspec
BP2 Not assessed Not assessed: no paired pathogenic PTEN variant or documented cis/trans/phase observation is available to satisfy the BP2 rule.
cspec
BP3 N/A Not applicable: the PTEN VCEP marks BP3 as unavailable, and p.E242Lfs*15 is a truncating frameshift rather than an in-frame repeat-region deletion.
cspec
BP4 N/A Not applicable: c.722_723dup is a frameshift variant, outside BP4's calibrated missense or intronic/splice-region computational scope.
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN histories are documented.
cspec oncokb
BP6 N/A Not applicable: BP6 is excluded by the PTEN framework, and ClinVar has no exact-variant expert-panel Benign or Likely benign assertion.
cspec clinvar
BP7 N/A Not applicable: c.722_723dup is a frameshift variant, not a synonymous variant eligible for BP7.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.